Gland Pharma Limited has informed the Exchange about the meeting of the members of ESOP Compensation Committee of Board of Directors of Gland Pharma Limited
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges that a meeting of the ESOP Compensation Committee will be held on Thursday, May 22, 2025. The committee will consider and approve the grant of Employee Stock Options (Grant I) under the company's Employee Option Scheme 2025. The company is led by Sampath Kumar Pallerlamudi, Company Secretary & Compliance Officer, who issued the intimation. No specific details on the number of options, grant price, or employee categories have been disclosed yet.
This is a routine intimation and typically has a neutral or mildly dilutive effect, as the grant of stock options can increase the share count over time. Shareholders should watch for the post-meeting outcome on May 22 for details on the size and pricing of the grant.